Antibiotic Treatment for Acute Uncomplicated Diverticulitis
For low-risk patients with acute uncomplicated diverticulitis (immunocompetent, hemodynamically stable, no fever/tachycardia/leukocytosis, tolerating oral intake, with reliable follow-up), antibiotics should be withheld; however, antibiotics are indicated for patients with immunocompromise, frailty, significant comorbidities, inability to tolerate oral intake, elevated inflammatory markers, or concerning imaging features. 1
When to Use Antibiotics: Risk Stratification
The 2026 ACG guidelines provide clear criteria for determining which patients require antibiotics 1:
Patients Appropriate for Non-Antibiotic Management (ALL must be present):
- Immunocompetent
- Outpatient candidate
- No complicated disease on imaging
- Hemodynamically stable
- No systemic inflammatory response (no fever, tachycardia, or leukocytosis)
- Not medically frail
- Tolerating oral intake
- No recent antibiotic use
- Reliable follow-up and adequate social support
Antibiotics ARE Indicated For:
- Immunocompromise
- Frailty or significant comorbid conditions
- Clinical deterioration or persistent/worsening symptoms
- Inability to tolerate oral intake or vomiting
- Elevated inflammatory markers (markedly elevated C-reactive protein)
- High-risk imaging features (fluid collection, longer segment of inflammation)
- Inadequate outpatient support or inability to ensure close follow-up
Antibiotic Regimens and Dosages
When antibiotics are indicated, the 2026 ACG guidelines recommend the following outpatient regimens 1:
Monotherapy Options:
- Amoxicillin-clavulanic acid 875 mg/125 mg orally every 12 hours
- Moxifloxacin 400 mg orally daily
Combination Therapy:
Metronidazole 500 mg orally every 8 hours PLUS one of the following:
- Trimethoprim-sulfamethoxazole (1 double strength tablet, 160/800 mg) every 12 hours, OR
- Ciprofloxacin 500 mg every 12 hours, OR
- Levofloxacin 500 mg every 24 hours
Duration of Treatment:
4-7 days is the usual duration 1
Important Clinical Considerations
Amoxicillin-clavulanate is preferred over fluoroquinolone combinations when possible, as it appears equally effective while reducing the risk of fluoroquinolone-associated harms, including Clostridioides difficile infection 1. This represents an important safety consideration that should influence antibiotic selection.
The evidence supporting selective antibiotic use comes from multiple RCTs showing that in appropriately selected low-risk patients, antibiotic treatment does not significantly improve quality of life, complications, or need for surgery compared to no antibiotics 2. However, antibiotics may slightly decrease treatment failure (absolute risk difference of -2.2%) 2.
Critical Pitfalls to Avoid
Do not reflexively prescribe antibiotics for all diverticulitis cases - this represents outdated practice that increases antibiotic resistance and adverse effects without improving outcomes in low-risk patients
Ensure close follow-up within 48-72 hours for patients managed without antibiotics, as a small proportion develop complications within the first 10 days 1
Do not use mesalamine or rifaximin for prevention of recurrence - these are specifically recommended against by guidelines 1
Recognize that immunocompromised patients always require antibiotics - this includes patients on chronic steroids, chemotherapy, or with HIV/AIDS 1
Inpatient Antibiotic Regimens
For patients requiring hospitalization (complicated diverticulitis, sepsis, inability to tolerate oral intake), intravenous antibiotics are indicated. While the guidelines focus primarily on outpatient management, historical regimens include IV combinations such as gentamicin plus clindamycin, cefoxitin, or ertapenem 2. The specific inpatient regimen should provide coverage against gram-negative and anaerobic organisms.